Skin Cancer

Low-dose retinoids prevented cutaneous SCC in organ transplant recipients

Published in Clinical Oncology Week, May 30th, 2005

Low-dose retinoids might lower the incidence of cutaneous squamous cell carcinomas (SCCs) in organ transplant recipients (OTRs).

In a recent article published in the journal Archives of Dermatology, scientists in England conducted a study "to evaluate the long-term efficacy of systemic retinoids in reducing the incidence of cutaneous SCCs in OTRs, who are at greatly increased risk of SCCs."

"A retrospective before-after study of OTRs who had received low-dose systemic retinoids during 1 to 16 years for prevention of SCCs [in] a specialist dermatology clinic for organ transplant recipients at St. Bartholomew's and the Royal London Hospital [was...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2005-05-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry